Related Experiment Video

Updated: Aug 12, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

New paradigms for cancer drug discovery

Jason A Sager1, Christoph Lengauer

  • 1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.

Cancer Biology & Therapy
|September 26, 2003
PubMed

Insights

Drug discovery is shifting, with academic institutions increasingly developing cancer therapies. This evolution may lead to novel cancer drugs complementing those from large pharmaceutical companies.

Area of Science:

  • Oncology
  • Pharmacology
  • Biotechnology

Background:

  • Traditional drug discovery is dominated by large pharmaceutical companies, leading to high medication costs.
  • Despite significant investment, cancer therapy success has remained limited over the past decade.
  • The established drug discovery paradigm faces challenges in delivering effective cancer treatments.

Purpose of the Study:

  • To analyze critical elements of the cancer drug discovery process.
  • To explore the emerging role of academic institutions in developing cancer drugs.
  • To assess the potential for academic research to complement pharmaceutical industry contributions.

Main Methods:

  • Review of current drug discovery processes in oncology.
  • Analysis of the capabilities and trends in academic research programs.
  • Comparative examination of drug development pipelines in academia versus industry.

Main Results:

  • Academic institutions are actively initiating their own drug discovery programs.
  • The traditional model of drug discovery is being challenged by new approaches.
  • There is a growing potential for academic research to yield novel cancer therapeutics.

Conclusions:

  • The landscape of cancer drug discovery is evolving, with academia playing a more prominent role.
  • Future cancer drug development is likely to involve a collaborative effort between academic institutions and pharmaceutical companies.
  • Academic-driven research offers a promising avenue for discovering innovative cancer therapies.

More Related Videos

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures07:48

Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures

Published on: December 26, 2016

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...